GE, Cardinal Health expand access to cardiac imaging agent
Cardinal Health and GE Healthcare have entered an agreement to increase the availability of GE’s Myoview through Cardinal Health's network of specialized nuclear pharmacies.
The agreement will give Cardinal Health's customers greater access to the cardiac imaging agent, which is a leading myocardial perfusion imaging technetium agent used in the diagnosis and treatment of heart disease.
The Dublin, Ohio-based Cardinal Health operates a radiopharmacy network in the United States with more than 150 nuclear pharmacy locations.
The agreement will give Cardinal Health's customers greater access to the cardiac imaging agent, which is a leading myocardial perfusion imaging technetium agent used in the diagnosis and treatment of heart disease.
The Dublin, Ohio-based Cardinal Health operates a radiopharmacy network in the United States with more than 150 nuclear pharmacy locations.